Background illustration for clinical trials search

Prostate Cancer Clinical Trials

Browse 764 prostate cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: New York NY, Durham NC, Madison WI
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT06141993

Recruiting

Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)

for
Prostate Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: Male

Age: 18+

Code: NCT06177093

Recruiting

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

for
Prostate Cancer, Biochemically Recurrent
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05588128

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Stony Brook NY, Bay Shore NY, Lake Success NY,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting

Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 18+

Code: NCT04992728

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

for
High-risk Prostate Cancer, Prostate Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: Male

Age: 18+

Code: NCT03541928

Phase2, Recruiting

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

for
Prostate Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Male

Age: 18+

Code: NCT06099093

Recruiting

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

for
Recurrent Prostate Cancer
Location: New York NY, Toronto
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT03067051

Phase1, Phase2, Recruiting

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 0+

Code: NCT05882253

Recruiting

Early Prostate Cancer: Predicting Treatment Response

for
Prostate Cancer
Location: Irvine CA, Long Beach CA, Los Angeles CA,
Sponsor: University of California, Irvine

Sex: Male

Age: 18 - 70+

Code: NCT03770351

Recruiting

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

for
Breast Cancer, Prostate Cancer, Vertebral Metastasis, Pain
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 35 - 70+

Code: NCT00294151

Phase3, Recruiting

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Durham NC, Ann Arbor MI, Madison WI, Los Angeles CA,
Sponsor: Syntrix Biosystems, Inc.

Sex: Male

Age: 18+

Code: NCT06228053

Phase2, Recruiting

A Study of Mental Health Care in People With Cancer

for
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 65+

Code: NCT06037954

Recruiting

Comprehensive Assessment of Cancer Theranostic Response

for
Prostate Cancer
Location: New York NY, Houston TX
Sponsor: AIQ Solutions

Sex: Male

Age: 18+

Code: NCT06815354

Recruiting

18F-DCFPyL PET-CT Scan and Prostate Cancer

for
Prostate Cancer Adenocarcinoma
Location: Los Angeles CA
Sponsor: Lida Jafari

Sex: Male

Age: 18+

Code: NCT03852654

Phase2, Phase3, Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: Boston MA, New York NY, Chicago IL, Kansas City KS,
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06274047

Phase3, Recruiting

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

for
Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 50+

Code: NCT06451445

Recruiting

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

for
Prostate Cancer, Lower Urinary Tract Symptoms
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT03802851

Recruiting

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

for
Prostate Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male

Age: 18+

Code: NCT06347705

Phase2, Recruiting

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

for
Advanced Prostate Cancer, Metastatic Prostate Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Male

Age: 18+

Code: NCT06062745

Phase1, Recruiting